Ha Yun-Sok, Kim Sang Won, Chun So Young, Chung Jae-Wook, Choi Seock Hwan, Lee Jun Nyung, Kim Bum Soo, Kim Hyun Tae, Yoo Eun Sang, Kwon Tae Gyun, Kim Won Tae, Kim Wun-Jae, Kim Tae-Hwan
Department of Urology, School of Medicine, Kyungpook National University, Daegu, South Korea.
Department of Urology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, South Korea.
BMC Urol. 2019 Jan 24;19(1):10. doi: 10.1186/s12894-019-0439-7.
New biological prognostic predictors have been studied; however, some factors have limited clinical application due to tissue-specific expression and high cost. There is the need for a promising predictive factor that is simple to detect and that is closely linked to oncological outcomes in patients with urothelial bladder cancer (BC) who have undergone radical cystectomy (RC). Therefore, we investigated the clinical prognostic value of the preoperative De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) on oncological outcomes in patients with urothelial BC after RC.
We retrospectively evaluated clinicopathological data of 118 patients with non-metastatic urothelial BC after RC between 2008 and 2013 at a single center. The association between the De Ritis ratio and clinicopathological findings was assessed. The potential prognostic value of the De Ritis ratio was analyzed using the Kaplan-Meier method, and multivariate Cox analyses were performed to identify the independent predictors of metastasis-free survival, cancer-specific survival, and overall survival.
According to the receiver operating curve of the De Ritis ratio for metastasis, we stratified the patients into 2 groups using a threshold of 1.3. A high De Ritis ratio was more likely to be associated with old age and the female sex. Kaplan-Meier estimates revealed that patients with a high De Ritis ratio had inferior metastasis-free survival, cancer-specific survival, and overall survival outcomes (P = 0.012, 0.024, and 0.022, respectively). Multivariate analysis revealed that a high De Ritis ratio was an independent prognostic factor for metastasis (hazard ratio [HR], 2.389; 95% confidence interval [CI], 1.161-4.914; P = 0.018), cancer-related death (HR, 2.755; 95% CI, 1.214-6.249; P = 0.015), and overall death (HR, 2.761; 95% CI, 1.257-6.067; P = 0.011).
An elevated De Ritis ratio was significantly associated with worse prognosis in patients who underwent RC for urothelial BC. This ratio might further improve the predictive accuracy for prognosis in BC.
新型生物预后预测指标已得到研究;然而,一些因素因组织特异性表达和高成本而临床应用受限。对于接受根治性膀胱切除术(RC)的尿路上皮膀胱癌(BC)患者,需要一种易于检测且与肿瘤学结局密切相关的有前景的预测因素。因此,我们研究了术前De Ritis比值(天冬氨酸转氨酶/丙氨酸转氨酶)对RC术后尿路上皮BC患者肿瘤学结局的临床预后价值。
我们回顾性评估了2008年至2013年在单中心接受RC的118例非转移性尿路上皮BC患者的临床病理数据。评估了De Ritis比值与临床病理结果之间的关联。使用Kaplan-Meier方法分析De Ritis比值的潜在预后价值,并进行多变量Cox分析以确定无转移生存期、癌症特异性生存期和总生存期的独立预测因素。
根据De Ritis比值对转移的受试者工作特征曲线,我们使用1.3的阈值将患者分为两组。高De Ritis比值更可能与老年和女性相关。Kaplan-Meier估计显示,高De Ritis比值的患者无转移生存期、癌症特异性生存期和总生存期结局较差(分别为P = 0.012、0.024和0.022)。多变量分析显示,高De Ritis比值是转移(风险比[HR],2.389;95%置信区间[CI],1.161 - 4.914;P = 0.018)、癌症相关死亡(HR,2.755;95% CI,1.214 - 6.249;P = 0.015)和总死亡(HR,2.761;95% CI,1.257 - 6.067;P = 0.011)的独立预后因素。
De Ritis比值升高与接受RC治疗的尿路上皮BC患者的预后较差显著相关。该比值可能进一步提高BC预后的预测准确性。